Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

[News]

Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.

More... (https://www.news-medical.net/news/20171117/Mount-Sinai-researchers-identify-new-therapeutic-target-for-ER2b-breast-cancer.aspx)